Gastro-oesophageal Reflux

References

  1. Cadière GB. Cirugia functional del estomago por laparoscopia. In: Ballesta Lopez C. eds. Laparoscopia quirurgic. Barcelona: Video Medica. 1992 : 83-98.
  2. Cadière GB. Treatment of pathologic gastro-oesophageal reflux : Nissen’s technique. VRC mai-juin 1992, 9 (3) : 7-17.
  3. Cadière GB. Points clés et résultats de la cure coelioscopique du reflux gastro-oesophagien. Rév Française de Gastro-entérologie 1993, 292 : 309- 311.
  4. Cadière GB. Laparoscopic Nissen fundoplication. Hepato-gastroenterology 1997, 44 : 4-10.
  5. Cadière GB, Houben JJ, Bruyns J, Himpens J, Panzer JM, Gelin M. Laparoscopic Nissen fundoplication : technique and preliminary results. Br J Surg 1994, 81 : 400-403.
  6. Cadière GB. La chirurgie anti-reflux : indication, principe, et apport de la coelioscopie. Rev Méd Brux 1994, 15 : 25-30.
  7. Champault G, Cadière GB, Dulucq JL, Collet D. Reflux gastro-oesophagien, traitement par laparoscopie : 940 cas - expérience française. Ann Chir 1994, 48 (2) : 159-164.
  8. Cadière GB. Technique d’abord de l’hiatus oesophagien par coelioscopie. In Actualités Digestives Médico-Chirurgicale, eds Masson Jean Mouiel, Paris pp 18-19.
  9. Cadière GB, Himpens J, Bruyns J. Fundoplicature selon Nissen par coeliovidéoscopie. Ann Chir 1995, (1) : 24-29.
  10. Cadière GB. Traitement du reflux gastro-oesophagien par coelio-vidéoscopie. Encyclopédie Médico-Chirurgicale, 1995; 40-189 : pp9.
  11. Cadière GB, Himpens J, Bruyns J. How to avoid oesophageal perforation while performing laparoscopic dissection of the hiatus. Surg Endosc 1995; 9:540-452.
  12. Cadière GB, Collet D. Traitement laparoscopique du reflux gastro- oesophagien pathologique : faisabilité et complications. A propos de 1313 cas. Lyon chir, 91/2; 1995, pp 94-97.
  13. Collet D., Cadière GB. Conversion and complications of laparoscopic treatment of gastro-esophageal reflux disease. Am J Surg, 1995, vol 169, pp 622-626.
  14. Rajan A., Cadière GB. Traitement du reflux gastro-oesophagien pathologique. Journal de coelio-chirurgie, n°14 juin 1995, pp 23-28.
  15. Maton PN. Omeprazole. N Engl. J. Med 1991, 324 : 965-967.
  16. Dent J, MackinsonM, Reed W et al. Omeprazole prevents relapse of peptic oesophagitis. World Congr Gastroenterology, Sydney, Australie, 1990, FP4.
  17. Galmiche JP, Janssens J, Mainguet P et Van Trappen G. Reflux Gastro- esophagien et oesophagite peptique. Excerpta Medice,Amsterdam 1994.
  18. Rope II CE. Acid reflux disorders. The New Engl J Med 1994, 331:656-660.
  19. Harvey RF, Gordon PC, Hadley N et al. Effects of sleeping with bed head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987, 2: 1200-1203.
  20. Mittal RK, Rochester DF, Mc Callum RW. Sphincteric action of the diaphragm during a relaxed lower oesophageal sphincter in humans. Am J Physiol 1989, 256 : G 136-144.
  21. Helm JF, Dodds WJ, Riedel OR et al. Determinants of oesophageal acid clearance in normal subjects. Gastroenterology 1983, 85 : 607-612.
  22. Hirschowitz BI. A critical analysis with appropriate controls of gastric acid and pepsin secretion in clinical oesophagitis. Gastroenterology 1991, 101 : 1149- 1158.
  23. Goldberg HI, Dodds WJ, Gee S et al. Role of acid and pepsin in acute experimental oesophagitis gastroenterology 1969, 56 : 223-230.
  24. Stray SS, Eggli D, Mc Donald C, Johnson LF. Gastric emptying of solid food in patients with GER. Gastroenterology 1987, 92:459-465.
  25. Orlando RC. Esophageal epithelial resistance. J Clin Gastroenterol 1986, suppl 1: 12-16.
  26. Dent J, Holloway RH, Touli J, Dodds WJ. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastro-oesophageal reflux. Gut 1988, 29 : 1020.
  27. Kahrilas PJ, Dodds WJ, Hogan WJ et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986, 91 : 897-904.
  28. Bombeck CT. Gastrooesophageal reflux. In: Lloyd M. Nyhus, Wastell C. eds. Surgery of the stomach and duodenum. Boston: Little Brown and company. 1980:627-62.
  29. Joris J, Cigarini I, Legrand M. et al. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. Br. J. Anaest. 1992; 69 : 341-5.
  30. Holzman M, Sharp K, Richards W. Hypercarbia during carbon dioxide gas insufflation for therapeutic laparoscopy : a note of caution. Surg. Laparosc. Endosc. 1992; 2: 11-4.
  31. Barkun JS, Barkun AN, Sampalis JS et al. Randomised controlled trial of laparoscopic versus mini cholecystectomy. The Lancet 1992; 340 : 1116-19.
  32. Vital GD, Collet D, Larson GM et al. Interruption of professional and home activity after laparoscopic cholecystectomy among French and American patients. Am J. Surg. 1991; 161 : 396-8.
  33. Phillips EH, Franklin M, Carroll BJ et al. Laparoscopic colectomy. Ann. Surg. 1992; 216:703-7.
  34. Shantha TR, Harden J. Laparoscopic cholecystectomy : Anesthesia-related complications and guidelines. Surg. Laparosc. Endosc. 1991; 3 : 173-8.
  35. Launois B, Paul JL, Teboul F et al. Les résultats fonctionnels du traitement chirurgical du reflux gastro-oesophagien non compliqué. Ann de Chir. 1988; 42: 191-6.
  36. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastrooesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg 1986; 204 : 9-20.
  37. Nègre JB. Post-fundoplication symptoms: do they restrict the success of Nissen fundoplicatio ? Ann Surg 1983; 198 : 698-700.
  38. Bombeck CT, Helfrich G.B, Nyhus LM. Planning surgery for reflux oesophagitis and hiatus hernia. Surg. Clin. North Am. 1970; 50: 29-44.
  39. Jamieson GG, Myers JC. The relationship between Intra-Operative Manometry
    and Clinical Outcome in Patients Operated on for Gastro-Oesophageal
    Reflux Disease. World J. Surg. 1992; 16 : 337-40.
  40. Johnsson F, Joelsson B, Gudmundsson K et al. Effects of fundoplication on the antireflux mechanism. Br. J. Surg. 1987; 74 : 1111-14.
  41. Dallemagne B, Weerts JM, Jehaes C et al. Laparoscopic Nissen Fundoplication:Preliminary report. Surg. Laparosc. Endosc. 1991; 1: 138-43.
  42. Kuipers EJ, Wyterlinde AM, Salvador Pene A et al. Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy : implication for long term safety. Am J Gastroenterol 1995, 90 (9) : 1401-1406.
  43. 43. Dent J, Yeonans NDY, Mackinnon J, Read W, Narielvala FM, Hetzel DJ, Solva E and Shearman DJC. Omeprazole versus ramitidine for prevention of relapse in reflux oesophagitis : a controlled double blend trial of their efficacy and safety. Gut, 1994; 35 : 990-998
  44. 44. Hattlebakh JG and Berstad A. Laryphrazole 15 mg and 30 mg daily in maintening leaking and symptome relief in patients with reflux oesophagitis. Aliment. Pharmacol. Ther., 1998; 11 : 365-372
  45. 45. Labenz J and Malfertheinei P. Helicobacter pylori in gastro-oesophageal reflux disease : causal agent, independed on protective factor ? Gut, 1997; 41:277-280
  46. 46. Bardkar KD, Muller-Lissner S, Bigard MA, Bianchi-Pooro G, Ponce J, Hosée J, Scott M, Weir DG, Gillon K, Peacock P and Fulton C for the European study group. Symptomatic gastro-oesophageal reflux disease (GERD) intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management. Gastroenterololy, 1997: 112: A65
  47. 47. Bardhan KD. Reflux rising - a burning issue! A personal overview of treatment. Research and Clinical Forums 1998 vol 20 nr 2 : 27-